168 related articles for article (PubMed ID: 16484597)
1. LXR activation reduces proinflammatory cytokine expression in human CD4-positive lymphocytes.
Walcher D; Kümmel A; Kehrle B; Bach H; Grüb M; Durst R; Hombach V; Marx N
Arterioscler Thromb Vasc Biol; 2006 May; 26(5):1022-8. PubMed ID: 16484597
[TBL] [Abstract][Full Text] [Related]
2. LXR activation inhibits chemokine-induced CD4-positive lymphocyte migration.
Walcher D; Vasic D; Heinz P; Bach H; Durst R; Hausauer A; Hombach V; Marx N
Basic Res Cardiol; 2010 Jul; 105(4):487-94. PubMed ID: 20364260
[TBL] [Abstract][Full Text] [Related]
3. PPAR activators as antiinflammatory mediators in human T lymphocytes: implications for atherosclerosis and transplantation-associated arteriosclerosis.
Marx N; Kehrle B; Kohlhammer K; Grüb M; Koenig W; Hombach V; Libby P; Plutzky J
Circ Res; 2002 Apr; 90(6):703-10. PubMed ID: 11934839
[TBL] [Abstract][Full Text] [Related]
4. Liver X receptor is a key regulator of cytokine release in human monocytes.
Myhre AE; Agren J; Dahle MK; Tamburstuen MV; Lyngstadaas SP; Collins AJ; Foster SJ; Thiemermann C; Aasen AO; Wang JE
Shock; 2008 Apr; 29(4):468-74. PubMed ID: 17724434
[TBL] [Abstract][Full Text] [Related]
5. Liver x receptor agonists inhibit cytokine-induced osteopontin expression in macrophages through interference with activator protein-1 signaling pathways.
Ogawa D; Stone JF; Takata Y; Blaschke F; Chu VH; Towler DA; Law RE; Hsueh WA; Bruemmer D
Circ Res; 2005 Apr; 96(7):e59-67. PubMed ID: 15790955
[TBL] [Abstract][Full Text] [Related]
6. Activation of liver X receptor alleviates ocular inflammation in experimental autoimmune uveitis.
Yang H; Zheng S; Qiu Y; Yang Y; Wang C; Yang P; Li Q; Lei B
Invest Ophthalmol Vis Sci; 2014 Apr; 55(4):2795-804. PubMed ID: 24699378
[TBL] [Abstract][Full Text] [Related]
7. A nuclear receptor corepressor-dependent pathway mediates suppression of cytokine-induced C-reactive protein gene expression by liver X receptor.
Blaschke F; Takata Y; Caglayan E; Collins A; Tontonoz P; Hsueh WA; Tangirala RK
Circ Res; 2006 Dec; 99(12):e88-99. PubMed ID: 17110595
[TBL] [Abstract][Full Text] [Related]
8. Endoglin (CD105) expression is regulated by the liver X receptor alpha (NR1H3) in human trophoblast cell line JAR.
Henry-Berger J; Mouzat K; Baron S; Bernabeu C; Marceau G; Saru JP; Sapin V; Lobaccaro JM; Caira F
Biol Reprod; 2008 Jun; 78(6):968-75. PubMed ID: 18276933
[TBL] [Abstract][Full Text] [Related]
9. Ligand, receptor, and cell type-dependent regulation of ABCA1 and ABCG1 mRNA in prostate cancer epithelial cells.
Trasino SE; Kim YS; Wang TT
Mol Cancer Ther; 2009 Jul; 8(7):1934-45. PubMed ID: 19531574
[TBL] [Abstract][Full Text] [Related]
10. Suppression of beta-catenin signaling by liver X receptor ligands.
Uno S; Endo K; Jeong Y; Kawana K; Miyachi H; Hashimoto Y; Makishima M
Biochem Pharmacol; 2009 Jan; 77(2):186-95. PubMed ID: 18983830
[TBL] [Abstract][Full Text] [Related]
11. Liver X receptor agonist regulation of Th17 lymphocyte function in autoimmunity.
Xu J; Wagoner G; Douglas JC; Drew PD
J Leukoc Biol; 2009 Aug; 86(2):401-9. PubMed ID: 19406833
[TBL] [Abstract][Full Text] [Related]
12. Tissue-specific autoregulation of the LXRalpha gene facilitates induction of apoE in mouse adipose tissue.
Ulven SM; Dalen KT; Gustafsson JA; Nebb HI
J Lipid Res; 2004 Nov; 45(11):2052-62. PubMed ID: 15292368
[TBL] [Abstract][Full Text] [Related]
13. Association between liver X receptor-α and neuron-derived orphan nuclear receptor-1 in Kupffer cells of C57BL/6 mice during inflammation.
He K; Dai ZY; Li PZ; Zhu XW; Gong JP
Mol Med Rep; 2015 Oct; 12(4):6098-104. PubMed ID: 26239564
[TBL] [Abstract][Full Text] [Related]
14. IL-2 receptor blockade inhibits late, but not early, IFN-gamma and CD40 ligand expression in human T cells: disruption of both IL-12-dependent and -independent pathways of IFN-gamma production.
McDyer JF; Li Z; John S; Yu X; Wu CY; Ragheb JA
J Immunol; 2002 Sep; 169(5):2736-46. PubMed ID: 12193748
[TBL] [Abstract][Full Text] [Related]
15. T0901317 is a potent PXR ligand: implications for the biology ascribed to LXR.
Mitro N; Vargas L; Romeo R; Koder A; Saez E
FEBS Lett; 2007 May; 581(9):1721-6. PubMed ID: 17418145
[TBL] [Abstract][Full Text] [Related]
16. Activated T lymphocytes regulate hyaluronan binding to monocyte CD44 via production of IL-2 and IFN-gamma.
Levesque MC; Haynes BF
J Immunol; 2001 Jan; 166(1):188-96. PubMed ID: 11123292
[TBL] [Abstract][Full Text] [Related]
17. Cross-talk between peroxisome proliferator-activated receptor (PPAR) alpha and liver X receptor (LXR) in nutritional regulation of fatty acid metabolism. II. LXRs suppress lipid degradation gene promoters through inhibition of PPAR signaling.
Ide T; Shimano H; Yoshikawa T; Yahagi N; Amemiya-Kudo M; Matsuzaka T; Nakakuki M; Yatoh S; Iizuka Y; Tomita S; Ohashi K; Takahashi A; Sone H; Gotoda T; Osuga J; Ishibashi S; Yamada N
Mol Endocrinol; 2003 Jul; 17(7):1255-67. PubMed ID: 12730332
[TBL] [Abstract][Full Text] [Related]
18. Liver X receptor agonist methyl-3β-hydroxy-5α,6α-epoxycholanate attenuates atherosclerosis in apolipoprotein E knockout mice without increasing plasma triglyceride.
Yan W; Zhang T; Cheng J; Zhou X; Qu X; Hu H
Pharmacology; 2010; 86(5-6):306-12. PubMed ID: 21071998
[TBL] [Abstract][Full Text] [Related]
19. Liver X receptor activator downregulates angiotensin II type 1 receptor expression through dephosphorylation of Sp1.
Imayama I; Ichiki T; Patton D; Inanaga K; Miyazaki R; Ohtsubo H; Tian Q; Yano K; Sunagawa K
Hypertension; 2008 Jun; 51(6):1631-6. PubMed ID: 18443233
[TBL] [Abstract][Full Text] [Related]
20. Identification of interferon-γ as a new molecular target of liver X receptor.
Wang Q; Ma X; Chen Y; Zhang L; Jiang M; Li X; Xiang R; Miao R; Hajjar DP; Duan Y; Han J
Biochem J; 2014 Apr; 459(2):345-54. PubMed ID: 24438183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
